Underutilization of Medications for Heart Patients in Saudi Arabia
Author Information
Author(s): Assiri Abdullah S.
Primary Institution: King Khalid University
Hypothesis
What factors predict the use of adjunctive pharmacotherapy in ACS patients?
Conclusion
Certain adjunctive pharmacotherapies were underutilized in ACS patients in Southwest region, Saudi Arabia, specifically β-blockers and ACEI.
Supporting Evidence
- β-blockers and ACEI were used in only 69% and 59% of cases, respectively.
- Aspirin, clopidogrel, and statin were used in 98.4%, 82.6%, and 89.3% of cases, respectively.
- Survival rate at discharge was 95.6%.
- Use of statin and aspirin improved survival.
Takeaway
Doctors are not giving enough heart medications to patients who need them, which can make it harder for them to get better.
Methodology
A retrospective cohort study of 562 patients admitted with ACS was conducted, analyzing their medication use and survival rates.
Potential Biases
Potential biases may arise from physician attitudes and patient compliance with treatment.
Limitations
The study is limited to a single hospital and may not represent broader practices.
Participant Demographics
407 men (72.4%) and 155 women (27.6%), average age 60.6 years, majority were Saudis (89.3%).
Statistical Information
Confidence Interval
95% CI provided for various factors affecting medication use and survival.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website